Rheumatology Nurse Practice: Treatment Pathways in Ankylosing Spondylitis

0 Lessons
Start Course

Activity Description

In this issue of Rheumatology Nurse Practice, we will review evidence-based treatment pathways aimed at improving patients’ AS symptoms that may allow them to better function and enjoy their lives. We will focus on the latest clinical guidelines both for patients newly diagnosed with AS as well as those who have not responded to prior therapies. In addition, we will discuss how to manage some of the more
common extra-articular manifestations and comorbidities of AS, including uveitis, inflammatory bowel disease (IBD), psoriasis, and cardiac disease.

Target Audience

This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

Learning Objectives

After participating in the activity, learners should be better able to:

    • Discuss the importance of prompt diagnosis and treatment of patients with ankylosing spondylitis (AS)
    • Identify key concepts included within consensus guidelines for the diagnosis and treatment of AS
    • Assess the general efficacy and safety of biologic therapies approved for the treatment of AS based on published clinical trial results
    • Develop strategies to help overcome common patient adherence hurdles to AS treatment regimens.

Accreditation and Credit Designation

Rheumatology Nurses Society is accredited with distinction as a provider of continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No.P0500).

Participants will receive 2.75 hours of continuing nursing contact hours, including 1.75 pharmacotherapeutic hours, by completing the education, completing an online evaluation, and receiving a post-test score of 70%.

Disclosure Statement

According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of

Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.

Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education, with the exception of the following:

Carrie Beach, RN-BC, BSN, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Janssen/C, Aurinia/SB.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information, including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please go to and complete the post-test (achieving a passing grade of 70% or greater) and program evaluation. Your certificate will be available to you upon completion.


© 2022. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission for its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).


This course will expire on February 15, 2023